Related Experiment Video
Updated: Aug 23, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Evaluation of a type 2 diabetes screening protocol in an urban pediatric clinic
Stephanie Drobac1, Wendy Brickman, Tiy Smith
1Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. sdrobac@peds.bsd.uchicago.edu
Insights
The American Diabetes Association type 2 diabetes screening protocol was inconsistently applied in an urban pediatric clinic, with acanthosis nigricans a key factor in identifying children for screening. Early identification is crucial for managing pediatric diabetes.
Area of Science:
- Pediatric Endocrinology
- Public Health
- Clinical Research
Background:
- The American Diabetes Association (ADA) established guidelines in 2000 for screening type 2 diabetes mellitus (T2DM) in children.
- Recommendations include testing children aged 10 years or older with a BMI at or above the 85th percentile for age, plus at least two risk factors.
Purpose of the Study:
- To evaluate the implementation of the ADA's T2DM screening protocol within an urban pediatric clinic setting.
- To describe the characteristics of the pediatric population screened and the application of the protocol.
Main Methods:
- A retrospective review of medical records for 997 patients aged 10-18 years during a 13-month period.
- Data collection included demographics, medical/family history, physical exams, counseling, and laboratory results.
- Body Mass Index (BMI) percentiles were calculated using national references.
Main Results:
- Nearly half (48%) of the subjects had a BMI at or above the 85th percentile, with 96% being Hispanic.
- Only 41% of eligible subjects met the criteria for T2DM screening.
- Screening was ordered for 38% of eligible patients, with acanthosis nigricans being a significant factor in identification.
Conclusions:
- The ADA T2DM screening protocol was inconsistently applied at this high-risk urban clinic.
- Acanthosis nigricans played a crucial role in identifying patients for screening.
- Screening was associated with increased nutritional counseling documentation, highlighting the need for further research on protocol effectiveness.
Background:
In 2000, the American Diabetes Association issued recommendations for type 2 diabetes mellitus screening among children. They recommended testing children > or =10 years of age who have a body mass index (BMI) of >85th percentile for age and at least 2 other risk factors (family history of type 2 diabetes, high-risk race/ethnicity, or evidence of insulin resistance, such as acanthosis nigricans).
Objective:
To describe the application of a type 2 diabetes mellitus screening protocol in an urban pediatric clinic. Design/Methods. Medical records for patients 10 to 18 years of age who were examined in health maintenance visits during a 13-month period were reviewed; 997 subjects were included in the analyses. Data collected included demographic features, medical history, family history, physical examination findings, dietary and physical activity counseling, and results of laboratory tests. BMI percentiles for age were determined from national references.
Results:
Subjects were 50% male (median age: 13.2 years), 96% Hispanic, and 48% (n = 477) had a >85th percentile BMI (including 26% with a > or=95th percentile BMI). Of the 477 subjects, 100% were in high-risk racial/ethnic groups, 29% had a family history of diabetes, and 20% demonstrated evidence of insulin resistance; 194 (41%) met the criteria for screening. Of those who met the criteria, 38% (n = 73) had screening ordered and 65 of those subjects (89%) completed screening. Acanthosis nigricans was more common among subjects for whom screening was ordered (69%), compared with subjects who were not screened (3%). Three screened subjects exhibited impaired glucose tolerance; none had overt diabetes. Subjects for whom screening was ordered were more likely to have received counseling than were subjects not recognized as qualifying for screening (84% vs 52%).
Conclusions:
At this high-risk clinical site, the American Diabetes Association type 2 diabetes screening protocol was inconsistently applied. Acanthosis nigricans was a driving factor in identification and screening. Recognition of the need for screening was associated with a higher rate of documentation of nutritional counseling. Additional evaluation of the effectiveness of screening protocols in the early identification of diabetes and the effects of screening protocols on long-term morbidity is needed.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...